Form4insider filings, from the source

SEC Form 4 · accession 0001645627-18-000043

ENDONOVO THERAPEUTICS, INC. · ENDV

Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗

Reporting owner
Michael Scott Mann
Officer — President · 10% Owner
Period of report
Aug 2, 2018
Accepted (ET)
Aug 8, 2018 · 1:21 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001528172

Table I — non-derivative securities

SecurityDateCodeSharesPriceA/DOwned afterD/INature of ownership
Common StockAug 2, 2018P2,000$0.0298A25,351,498D
Common StockAug 2, 2018P2,000$0.03A25,353,498D
Common StockAug 2, 2018P2,000$0.0307A25,355,498D
Common StockAug 2, 2018P5,000$0.0307A25,360,498D
Common StockAug 2, 2018P2,000$0.0306A25,362,498D
Common StockAug 2, 2018P2,000$0.0306A25,364,498D
Common StockAug 2, 2018P2,000$0.0329A25,366,498D
Common StockAug 3, 2018P2,000$0.0308A25,368,498D
Common StockAug 3, 2018P2,000$0.0309A25,370,498D
Common StockAug 3, 2018P1,000$0.0308A25,371,498D
Common StockAug 3, 2018P5,000$0.0306A25,376,498D
Common StockAug 3, 2018P2,000$0.0306A25,378,498D
Common StockAug 3, 2018P2,000$0.031A25,380,498D
Common StockAug 6, 2018P2,000$0.0284A25,382,498D
Common StockAug 6, 2018P3,000$0.0284A25,385,498D
Common StockAug 6, 2018P5,000$0.0293A25,390,498D
Common StockAug 6, 2018P2,000$0.0292A25,392,498D
Common StockAug 6, 2018P2,000$0.029A25,394,498D
Common StockAug 6, 2018P2,000$0.0294A25,396,498D
Common StockAug 6, 2018P3,000$0.0291A25,399,498D
Common StockAug 6, 2018P2,000$0.0291A25,401,498D
Common StockAug 6, 2018P1,000$0.0294A25,402,498D
Common StockAug 6, 2018P2,000$0.0291A25,404,498D
Common StockAug 6, 2018P3,000$0.0291A25,407,498D

Table II — derivative securities

No Table II lines on this filing.